BioPharm News

May 25, 2015
The House Energy Committee’s approval of the 21st Century Cures legislation is only a first step, with critics and collaborators alike lining up to comment.
May 25, 2015
By BioPharm International Editors
Visterra announces partnership with A*STAR to develop VIS513, a monoclonal antibody for the treatment of dengue fever.
May 25, 2015
By BioPharm International Editors
Boehringer Ingelheim announces FDA approval of Stiolto Respimat inhaler for the treatment of COPD.
May 24, 2015
By BioPharm International Editors
Epirus Biopharmaceuticals and mAbxience have entered into a development and future distribution deal for Epirus’ lead program, BOW015 (infliximab, reference biologic Remicade), for Latin American markets.
May 20, 2015
The House Energy and Commerce Committee gave unanimous approval to the landmark 21st Century Cures Act reform bill on May 21, 2015.
May 20, 2015
By BioPharm International Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 19, 2015
Physician confidence in biosimilars and extrapolation of indications are two of the most important factors governing the acceptance and sustainability of biosimilars, say industry panelists.
May 19, 2015
By BioPharm International Editors
The former New England Compounding Center will pay $200 million to victims and creditors for the 2012 outbreak of meningitis that killed 64.
May 19, 2015
By BioPharm International Editors
The Denmark facility will incorporate CMC’s Bioreactor 6Pack configuration in one manufacturing line.
May 18, 2015
By BioPharm International Editors
The Critical Path Institute launched a consortium to help develop therapies for newborns.